Jens Kuhn returns to TWiV to explain Select Agents, Priority Pathogens, Australia List Pathogens, Risk Group Agents, biosafety, biosecurity, and biosurety.
TWiV 508: Bioweapon
- August 26, 2018
- Tagged as: biocrime, biodefense, Biopreparat, bioterrorism, biowarfare, bioweapon, Soviet Union, vector, viral, virology, virus, viruses
Jens returns to present a brief history of bioweapons, with a focus on the program in the Soviet Union, the largest ever undertaken, and his experience working in the decommissioned Soviet bioweapons laboratory known as Vector.
TWiV 422: Watching the icosahedron drop
- January 1, 2017
- Tagged as: 2016 in review, animal model, ebolavirus, evolution, Harold Varmus, mosquito, mutualism, Vaccine, vector, viral, virology, virus, viruses, Zika virus
The TWiVestigators wrap up 2016 with a discussion of the year’s ten compelling virology stories.
From ASV 2016 at Virginia Tech, Vincent, Rich and Kathy speak with Stephen Russell about his career and his work on oncolytic virotherapy – using viruses to treat cancers.
Vincent speaks with Katherine High about her career and her work on using viral gene therapy to treat inherited disorders.
Vincent, Alan and Rich explain how to make a functional ribosome with tethered subunits, and review the results of a phase III VSV-vectored Ebolavirus vaccine trial in Guinea.
Vincent, Alan, Kathy, and Ashlee discuss fomites in physicians offices, plant virus factories involved in aphid transmission, and clues from the bat genome about flight and immunity.
TWiV 244: Back in the CVVR
- August 4, 2013
- Tagged as: adenovirus, AIDS, hiv, human immunodeficiency virus, innate immunity, poxvirus, STEP trial, Thai trial, Vaccine, vector, viral, virology, virus
This episode of TWiV was recorded before an audience at the Beth Israel Deaconess Medical Center, where Vincent and Alan spoke with Dan and Jeff about AIDS vaccines.
Vincent, Alan and Kathy review novel approaches to preventing influenza virus infection.
Welkin joins the TWiV team for a discussion of HIV prophylaxis using vectored antibodies, and the influenza H5N1 virus studies in ferrets that were not redacted.